Categories Earnings

Earnings Summary Of Dr Reddy ‘s Laboratories Limited For Q4 FY23

Dr. Reddy’s Laboratories Limited is an Indian multinational pharmaceutical company with a presence in over 25 countries. It was founded in 1984 and has its headquarters in Hyderabad, India. Dr. Reddy’s is a research-driven company with a focus on developing and manufacturing high-quality pharmaceutical products. The company operates in three main segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products.

  • Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth of 15.3%.
  • Total Expenses for Q4 FY23 of ₹5,132.2 Crore down from ₹5,348.4 Crore.
  • Consolidated Net Profit of ₹960.1 Crore, surged from ₹97 Crore in the same quarter of the previous year.
  • The Earnings per Share is ₹57.68, from ₹5.83 in the same quarter of the previous year.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,